Skip to main content
. 2017 Feb 3;8:14268. doi: 10.1038/ncomms14268

Table 3. S. aureus gene expression during infection of 4-APP-treated and MyD88-deficient C57BL/6 mice.

Locus tag Gene symbol Description Relative fold change in 4-APP-treated to vehicle-treated C57BL/6 mice (mean (s.e.)) Relative fold change in MyD88-deficient to wild type C57BL/6 mice (mean (s.e.))
SAOUHSC_02265 agrA Accessory gene regulator protein A −1.60 (0.22) −1.62 (0.5)
SAOUHSC_02566 sarR Accessory regulator R −1.83 (0.22) −1.23 (0.09)
SAOUHSC_01121 hla Alpha-hemolysin −3.32 (1.56) −18.06 (0.16)
SAOUHSC_02971 aur Zinc metalloproteinase aureolysin −2.31 (0.96) −2.59 (0.75)
SAOUHSC_00988 sspA Glutamyl endopeptidase −2.19 (0.01) −2.32 (0.46)
SAOUHSC_00561 vraX Protein VraX −3.91 (2.76) 1.11 (0.04)
SAOUHSC_00436 gltD Glutamate synthase subunit beta −2.41 (1.11) −6.03 (1.66)
SAOUHSC_01803 aapA D-serine/D-alanine/glycine transporter 1.21 (2.32) 1.69 (0.29)
  RNAIII Regulatory RNA −1.80 (0.53) −2.52 (0.08)

Level of expression of a subset of genes by S. aureus during infection of 4-APP-treated compared with vehicle-treated C57BL/6, respectively MyD88-deficient compared with wild-type C57BL/6 mice determined by quantitative reverse transcription–PCR (qRT–PCR).